Applications Published 31 October 2001
Published: 1-Jul-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Core tablet for controlled release of glicazide after oral administration
Adir et Compagnie 1148871*
Stable pharmaceutical formulation comprising a HMG -CoA reductase inhibitor
Lek Pharmaceutical and Chemical Co 1148872*
Highly-purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
Laxdale 1148873*
Use of anticonvulsant derivatives for treating bulimia nervosa
Ortho-McNeil Pharmaceutical 1148974*
Methods and compsns to enhance white blood cell count
Anormed 1148875*
Calcylitic compounds
SmithKline Beecham 1148876*
Methods for inhibiting bone resorption
Merck 1148877*
1,4,8,11-tetraazacyclodecatetradecane derivatives as radiodiagnostic agents and their use in determining hypoxia and radioresistance of tumours
Fox Chase Cancer Centre 1148878*
Use of pyrazole carboxamides
Bayer 1148879*
Methods for restoring and/or enhancing accomodation in pseudo phakia
Allergan Sales 1148880*
Use of pyridazino 4,5-b-indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
Sanofi-Synthelabo 1148881*
Pharmaceutical combination of progesterone and folic acid
Bogye, Gabor 1148882*
Method for treatment of headache
Winston Laboratories 1148883*
Graduated progestin contraceptive
Warner Chilcott LabroatoriesIreland 1148884*
Electrically-mediated enhancement of DNA vaccine immunity and efficacy in vivo
Chiron Corp 1148885*
Use of a polyanionic polysaccharide solution for the prevention of abscess formation
Genzyme 1148886*
Regulation of anaesthesia
Victoria University of Manchester 1148887*
Treatment of erectile dysfunctions with a C-type natriuretic polypeptide (CNP) as monotherapy or in combination with phosphodiesterase inhibitors
Forssmann, Wolf-Georg; Maegert, Hans-Juergen; Stief, Christian; Kuethe, Andrea; Ãœkert, Stefan; Becker, Armin; Jonas, Udo 1148888*
Method of treating demyelinating inflammatory disease using CCR1 antagonists
Millennium Pharmaceuticals 1148889*
Sterile substrate and process for producing it
Myocell Technologies 1148890*
Method of preparing alkylated salicylamides
Emisphere Technologies 1149066*
7-aryl-(Z)hepatatrienoic acid retinamides as apoptosis inducing compounds and their use as anticancer agents
F Hoffmann-La Roche 1149068*
Phenylglycine derivatives
F Hoffmann-La Roche 1149069*
Method for preparing methyl carbazate
Bayer 1149070*
Process for producing organic polysulphides
Philips Petroleum 1149071*
Sulphonamide hydroxamates
F Hoffmann-la Roche 1149072*
Process for producing 2-hydroxy-4-methylthio-butanoic acid
Sumitomo Chemistry 1149073*
Acetylenic sulphonamide thio TACE inhibitors
American Cyanamid 1149074*
Synthesis of dithioester chain transfer agents and use of bis(thioacyl) disulphides or dithioesters as chain transfer agents
DuPont 1149075*
O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically-acceptable salts and process for preparing the same
SK Corporation 1149076*
Method for the production of tetramethylthiuram disulphide
UCB 1149077*
Selective 5-HT 6 receptor ligands
Virginia Commonwealth University 1149078*
Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compsns containing same
SK Corp 1149079*
Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
Eli Lilly 1149080*
